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About 80% of all strokes are ischaemic stroke, and ischaemic stroke induces decreased brain blood flow, and triggers cascading events including inflammatory reaction, hypoxia, neurotoxicity of excitatory amino acids and cell apoptosis that may cause further cerebrovascular injuries and neuronal damage. 2 The most prominent pathological change in cerebral ischaemia is the neuronal death, which leads to the irreversible loss of brain function. 3 Growing evidence has suggested that neurons in the ischaemic penumbra or peri-infarct region may mostly undergo apoptosis so that they are potentially recoverable for some time after the onset of stroke. 4 Thus, it is important for us to elucidate the mechanisms underlying neuronal apoptosis, which may help us discover novel therapeutic approach in alleviating brain injury after ischaemic stroke.
Long non-coding RNAs (lncRNAs) are defined as a class of transcripts longer than 200 nucleotides without protein-coding potential. 5 Recently, accumulating studies have revealed that a number of lncRNAs are not transcriptional noise but have important functions including exerting enhancer-like activities, modulating transcription factor activity, recruiting histone modification complexes, co-activating with neighbouring genes, and acting as transcriptional enhancers. 6 A growing number of studies have demonstrated the aberrant expression of lncRNAs in various brain and neurodegenerative disorders. The lncRNA, small nucleolar RNA host gene 6
(SNHG6) is a housekeeping gene of the 5′-terminal oligopyrimidine tract family and associated with ribosomes. Currently, lncRNAs are found to exhibit differential functions in various human diseases, such as ischaemic stroke, hepatocellular carcinoma and breast cancer, and demonstrate the ability to affect cell transformation, metastasis and apoptosis. [7] [8] [9] Previous study has revealed that SNHG6
promoted oesophageal squamous cell carcinoma cell proliferation and inhibited cell apoptosis. 10 However, the functions and biological mechanisms of SNHG6 in the neuronal cells under ischaemic stroke condition have not yet been explored.
LncRNAs may functionally interact with a broad range of microRNA (miRNA) molecules through competitively binding with miRNAs, which results in miRNA degradation. This interaction have been discovered in various biological processes of human diseases such as ischaemic stroke and neurodegenerative diseases. 11, 12 Bcl-2-interacting mediator of cell death (BIM) belongs to the Bcl-2 family. Bcl-2 can be activated by various pro-apoptotic stimuli and promote cell death in a manner dependent on Bax and Bak.
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The role of BIM in ischaemic stroke has been elucidated in several studies. Meller et al, showed that rapid degradation of BIM mediated short-term ischaemic tolerance in cultured neurons 14 ; Arumugam et al, found that gamma-secretase-mediated notch signalling induced neuronal cell death via NF-κB-BIM pathway in ischaemic stroke. 15 In addition, studies also showed that the c-Jun N-terminal protein kinase signalling pathway mediated neurol apoptosis via interacting with BIM in focal cerebral ischaemia.
16
In this study, we assessed the differential expression of SNHG6 in a mice middle cerebral artery occlusion (MCAO) model and oxygen glucose deprivation (OGD)-induced cortical neuronal cells. The in vitro functional assays were performed to elucidate the underlying molecular mechanisms of SNHG6 in the pathogenesis of ischaemic stroke. MCAO surgery was used to induce focal cerebral ischaemia in mice as reported previously. 17 Mice were fasted 12 hours before surgery. Briefly, mice were anaesthetized by 3% chloral hydrate (300 mg/kg, ip.) and then right common carotid artery, internal carotid artery and external carotid artery were exposed. The nylon monofilament was used to occlude the middle cerebral artery. After 90 minutes of MCAO, reperfusion was accomplished by withdrawing the filament.
| MATERIAL S AND ME THODS

| In vivo mice MCAO model
| Determination of neurological deficit
The neurological deficits were evaluated after 24 hours of reperfusion. The neurological deficits in the MCAO mice were determined using 10-score system as reported previously. 18 The mice were eliminated from the experimental group with a neurobehavioural score <2.
| Determination of infarct volume
Brain infarct volume was determined to assess brain injury. The mice were killed, brains were removed quickly. The brain samples were frozen at −20°C and cut into 1 mm coronal sections. The sections were incubated in 1% 2, 3, 5-triphenyl-tetrazolium chloride (TTC; Sigma, St. Louis, USA) and fixed with 4% paraformaldehyde overnight to assess the size of infarction. 
| Primary mice cortical neuron culture
Primary mice cortical neuron culture was performed with a previously described method. 20, 21 The cortices were obtained from embryos of pregnant mice under sterile conditions. The cortices digested with trypsin-EDTA (1:1, 0.125%), then dissociated in minimum essential medium (MEM; Thermo Fisher Scientific, Waltham, USA) containing 10% foetal bovine serum (FBS; Thermo Fisher Scientific). After filtration, the cortical tissues were centrifuged at 1000 rpm for 5 minutes, and then resuspended in MEM with 10% FBS. Cortical neuron cells were plated into poly-l-lysine (10 mg/mL)-coated plates. Cells were grown in Neurobasal Medium (NBM) with 3% B27 (Sigma). Cultures were maintained for 8 days before treatment and the medium was changed every 3 days. 
| In vitro OGD model
| Cell viability
The cell viability of cortical neurons was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma)
assay. 24 The treated cells were incubated with 50 μL of MTT solution (5 mg/mL) for 4 hours. After incubation, the supernatant was removed and 150 μL dimethyl sulfoxide was added. Then the optical density (OD) value at 490 nm was measured by microplate reader (Bio-Tek, Winooski, USA).
| Apoptosis assay
Apoptosis assay was performed according to previously published methods. 20 Primary cortical neurons were collected from each group after different treatments. Cell apoptosis was detected by using an 
| Caspase-3 activity assay
The cortical neurons were incubated in 6-well plates after different treatments and the activity of caspase-3 was measured using
Caspase-3 Assay kit (Abcam, Cambridge, UK) according to the manufacturer's instruction.
| In vivo delivery of siRNAs into lateral ventricle of the mice
The in vivo administration of SNHG6 siRNA and scrambled siRNA were performed as described previously. 25 Briefly, the anaesthe- SNHG6 siRNA or control siRNA was injected into the animal brain (2 µL injection volume) using a Hamilton microsyringe at 1 day before MCAO surgery. 
| In vitro transfection
| Quantitative real-time PCR (qRT-PCR)
The total RNA and miRNAs from ischaemic brain tissues and cul- 
| Western blot
Total proteins were extracted from cells or tissues with radioimmunoprecipitation assay buffer on ice and the concentration of total protein was assessed by BCA assay (Bio-Rad, Hercules, USA). Equal 
| Luciferase reporter assay
To construct luciferase reporter vectors, SNHG6 fragments containing the predicted miR-181c-5p binding site (both wild-type and mutant) were amplified and cloned into the pGL3 luciferase vector (Promega, Madison, USA) and was named as SNHG6-WT and SNHG6-MUT, respectively. Cells were co-transfected with SNHG6-WT (or SNHG6-MUT) and miR-181c-5p mimic (or miR-NC) or inhibitor (or inhibitor-NC) using Lipofectamine 2000 reagent (Invitrogen).
At 48 hours post-transfection, cells were harvested and luciferase activity was analysed with the dual luciferase reporter assay system (Promega) according to the manufacturer's instruction. Similarly, pGL3 luciferase reporter vector was used to construct wild-type pGL3-miR-181c-5p 3′ untranslated region (3′UTR; miR-181c-5p-WT)
or mutated pGL3-miR-181c-5p 3′UTR (miR-181c-5p-MUT) vectors.
At 48 hours post-transfection, the cells were harvested and luciferase activity was analysed with the dual luciferase reporter assay system (Promega).
| RNA immunoprecipitation (RIP) assay
The physical interaction between SNHG6 and miR-181c-5p
was evaluated using the Magna RIP 
| Statistical analysis
The experimental data are expressed as mean ± standard deviation (SD). Statistical analysis was performed with the t-test or one-way analysis of variance (ANOVA) followed by Bonferroni's multiple comparison test. P < 0.05 was considered to statistically significant.
All statistical figures were plotted by using GraphPad Prism Version The changes of SNHG6 expression after focal ischaemic stroke were also determined in mice that were subjected to MCAO for 
| Knockdown of SNHG6 inhibits OGD-induced neuronal cells injury
To determine the role of SNHG6 in ischaemic stroke, we used OGD-induced cortical neurons to mimic ischaemic stroke in vitro.
As indicated in Figure 2A , no significant difference was found in SNHG6 expression between the OGD + si-NC group and OGD alone group. With the SNHG6 siRNA transfection, the SNHG6 expression in si-SNHG6 group or in OGD + si-SNHG6 group was decreased notably compared to their respective control groups. Silencing of SNHG6 promoted cell viability and decreased OGD-induced neuronal apoptosis ( Figure 2B,C) . Moreover, compared with OGD group, down-regulation of SNHG6 reduced caspase-3 activity ( Figure 2D ).
In general, these data indicated that silencing of SNHG6 inhibited OGD-induced neuron cells injury. 
| Knockdown of SNHG6 alleviates cerebral infarction and reduces neurological score
The infarct volume in the mice brain was detected by TTC staining. Viable brain tissue was stained with red colour and the infarct tissue remains white. As shown in Figure 3A ,B, no infarct area was detected in control group, while in the MCAO group, the infarct volume was increased significantly. Knockdown of SNHG6 markedly alleviated cerebral infarction volume when compared to MCAO + siNC group ( Figure 3A,B) . In addition, the neurological score increased significantly in the MCAO group, and compared with the OGD + si-NC group, mice in the SNHG6 siRNA group showed remarkably decreased neurological deficit ( Figure 3C ).
| SNHG6 directly binds to miR-181c-5p and negatively regulates its expression
Bioinformatics analysis was conducted using Diana tools and the results revealed that miR-181c-5p was one of the predicted targets ( Figure 4A ), and miR-181c-5p was selected for further study due to its regulatory role in cell apoptosis. [26] [27] [28] Transfection with miR-181c-5p mimic significantly increased the expression level of miR-181c-5p compared with mimic control group, and transfection with miR-181c-5p inhibitor down-regulated miR-181c-5p expression ( Figure 4B ).
The luciferase assay data showed that miR-181c-5p mimic transfection apparently inhibited the luciferase activity of the reporter vector containing SNHG6-WT, and miR-181c-5p inhibitor increased the luciferase activity; however, both miR-181c-5p mimic and inhibitor failed to influence the luciferase activity of reporter vector contain- and 24 hours after treatment compared to control group ( Figure 4H ).
We also determined changes of miR-181c-5p expression in brain tissues after MACO. Consistently, expression of miR-181c-5p in MCAO group was decreased evidently at 6, 24, 48 and 72 hours after surgery when compared to sham group ( Figure 4I ). These results indicated that SNHG6 directly bound to miR-181c-5p and negatively regulated the expression of miR-181c-5p.
| miR-181c-5p targets the 3′UTR of BIM and negatively regulates the expression of BIM
Bioinformatics analysis was conducted by using Targetscan tool, which revealed that BIM was one of the predicted genes targeted by miR-181c-5p ( Figure 5A ). The luciferase assay data showed that miR-181c-5p mimic transfection apparently inhibited the 
| D ISCUSS I ON
Stroke is defined as the clinical syndrome of rapid onset of focal or global cerebral deficit. 30 In recent years, stroke has become the second leading cause of death and the most important cause of disability in many countries. 31 In this study, we explored the role of SNHG6 In our study, we for the first time provided substantial evidence to demonstrate that SNHG6 was apparently up-regulated in mice MCAO brain tissues and OGD-induced cortical neuron cells, and our results suggest that knockdown of SNHG6 may alleviated the ischaemic stroke in the mice likely via inhibiting the cell apoptosis.
In recent years, ceRNA has been proposed as a new regulatory mechanism in multiple pathological and physiological processes. 34, 35 MiRNAs are a class of small non-coding RNA molecules with ~23 nucleotides in length, and regulated its downstream gene expression via targeting the 3′UTR of the genes. 36 In our study, we found that miR-181c-5p was a downstream target of SNHG6 and was negatively regulated by SNHG6. The miR-181 family is evolutionarily conserved and highly expressed in the brain, and has been implicated for its important roles in the cell processes including apoptosis. 37, 38 Our results further showed that knockdown of miR-181c-5p inhibited cell viability and increased cell apoptosis in cortical neurons and attenuated the effect of SNHG6 down-regulation on OGD-treated cortical neurons. Bioinformatics analysis showed that BIM was one potential target of miR-181c-5p.
BIM, as a member of BH3 Subfamily, plays an important role in the initiation and regulation of apoptosis, and studies have found that BIM was found to be overexpressed in the ischaemic regions in the mice and rat MCAO model. 39, 40 In vitro functional assays showed that miR-181c-5p could negatively regulate the expression of BIM, suggesting that miR-181c-5p plays an anti-apoptotic role through its inhibitory effect on BIM. In this study, we have demonstrated that overexpression of BIM inhibited cell viability and increased cell apoptosis in cortical neurons and attenuated the effect of SNHG6 down-regulation on OGD-treated cortical neurons, indicating that pro-apoptotic effects of SNHG6 by regulating miR-181c-5p/BIM signalling.
The present study also has some limitations. The expression of SNHG6 was only confirmed in the in vitro cell culture and in vivo animal models, and the role of SNHG6 from the clinical perspective should be determined in future studies. Based on the results from bioinformatics prediction, the downstream targets of SNHG6
were not limited to miR-181c-5p, and other predicted miRNAs may be investigated to consolidate the role of SNHG6 in ischaemic stroke. As SNHG6 affected the expression of BIM in the present study, whether SNHG6 also affected other apoptotic-related F I G U R E 6 SNHG6 functions as a ceRNA for miR-181c-5p to regulate BIM expression. A, Cell viability, B, cell apoptosis and C, caspase-3 activity were evaluated in cortical neurons transfected with miR-181c-5p inhibitor or inhibitor control (N = 3). D, Relative mRNA and protein expression levels of BIM in cortical neurons transfected with pcDNA3.1-BIM or pcDNA3.1 (N = 3). E, Cell viability, F, cell apoptosis and G, caspase-3 activity were evaluated in cortical neurons transfected with pcDNA3.1-BIM or pcDNA3.1 (N = 3). H, Cell viability, I, cell apoptosis and J, caspase-3 activity were measured in cortical neurons co-transfected with different siRNAs, miRNAs or plasmids (N = 3). Data were shown as mean ± SD *P < 0.05, **P < 0.01 and ***P < 0.001
proteins that interact with BIM should also be considered to further reveal the mechanistic role of SNHG6 in the regulation of cell apoptosis.
In conclusion, our study for the first time demonstrated that lncRNA SNHG6 functions as a ceRNA to regulate neuronal death by targeting miR-181c-5p/BIM signalling pathway in ischaemic stroke.
This study may provide a better understanding of the functions and potential mechanisms of SNHG6 in the pathogenesis of ischaemic stroke. Further may be warranted to clarify the molecular mechanisms of the cross-talk signalling pathway regulated by SNHG6 in the pathogenesis of ischaemic stroke.
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